Wolterink G, Phillips G, Cador M, Donselaar-Wolterink I, Robbins T W, Everitt B J
Department of Anatomy, University of Cambridge, UK.
Psychopharmacology (Berl). 1993;110(3):355-64. doi: 10.1007/BF02251293.
Several experiments investigated the involvement of D1 and D2 dopamine receptors in the ventral striatum in the control over behaviour by a conditioned reinforcer using an acquisition of new response procedure. Intra-accumbens infusion of either the D1 receptor antagonist, SCH 23390, or the D2 receptor antagonist, raclopride, completely blocked the potentiative effects of intra-accumbens d-amphetamine on responding with conditioned reinforcement and reduced responding to control levels. SCH 23390 was more potent than raclopride. At higher doses in the absence of d-amphetamine, both antagonists also blocked the preference for responding on the lever producing the conditioned reinforcer. Intra-accumbens infusions of either the D1 receptor agonist, SKF 38393, or the D2/3 receptor agonist, LY 171555 (quinpirole), selectively potentiated responding on the lever producing the conditioned reinforcer. Various combined infusions of the D1 and D2 agonists in specific low doses had additive, but not synergistic, effects on responding with conditioned reinforcement. None of the drugs affected the drinking of water in deprived subjects when infused intra-accumbens. These results suggest that both D1 and D2 receptors in the nucleus accumbens are involved in mediating the effects of dopamine in potentiating the control over behaviour by conditioned reinforcers.
多项实验利用新反应习得程序,研究了腹侧纹状体中D1和D2多巴胺受体在条件性强化物对行为控制中的作用。向伏隔核内注射D1受体拮抗剂SCH 23390或D2受体拮抗剂雷氯必利,均可完全阻断伏隔核内右旋苯丙胺对条件性强化反应的增强作用,并使反应降低至对照水平。SCH 23390比雷氯必利更有效。在无右旋苯丙胺的情况下,高剂量时两种拮抗剂均能阻断对产生条件性强化物的杠杆反应的偏好。向伏隔核内注射D1受体激动剂SKF 38393或D2/3受体激动剂LY 171555(喹吡罗),可选择性增强对产生条件性强化物的杠杆的反应。特定低剂量的D1和D2激动剂联合注射对条件性强化反应具有相加而非协同作用。向伏隔核内注射时,这些药物均不影响剥夺饮水的动物的饮水行为。这些结果表明,伏隔核中的D1和D2受体均参与介导多巴胺在增强条件性强化物对行为控制方面的作用。